Endologix Reports Fourth Quarter and Fiscal Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Endologix (ELGX) PT Lowered to $1.50 at RBC Capital
February 26, 2019 6:28 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Endologix (NASDAQ: ELGX) to $1.50 (from $2.00) while maintaining a Sector Perform rating.
The analyst notes 4Q18 revenues and 2019 guidance in line with preannouncement.
... MoreEndologix (ELGX) Posts Q4 Loss of $0.26/Share; Reaffirms FY19 Revenue Forecast
February 25, 2019 4:29 PM ESTEndologix (NASDAQ: ELGX) reported Q4 GAAP EPS of ($0.26), which may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $34.7 million versus the consensus estimate of $31.99 million.
Our performance in the fourth quarter and second half of the year reinforces confidence in our strategic planning process and our ability to implement... More
